No Significant Secondary Structural Change of α‐Synuclein Monomer by Site‐Specific DOPA or Phosphorylation Introduction in Its C‐Terminal Region
Journal of Peptide Science · 2026-09 · 32 (9)
DOI: 10.1002/psc.70118 ↗At a glance
Journal article in Journal of Peptide Science, published online on 2026-08-05. Written by Tatsuhito Matsuo and 7 co-authors. Institution: Department of Medical Radiology, Faculty of Health and Medical Sciences, Hiroshima International University, Higashi-Hiroshima, Hiroshima, Japan. Major MEDLINE topics: alpha-Synuclein, Dihydroxyphenylalanine. 50 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Japan Society for the Promotion of Science (JSPS) KAKENHI.
Abstract (original language)
α‐Synuclein (αSyn) is a major component of pathogenic Lewy bodies and Lewy neurites and is closely associated with Parkinson's disease. Among the various posttranslational modifications of αSyn, several have been implicated in the degeneration of dopaminergic neurons and are thought to promote Parkinson's disease through enhanced misfolding, aggregation, and accumulation of αSyn. Two such modifications, phosphorylation at Ser 129 (S129Phos) and hydroxylation at Tyr 136 (Y136DOPA), exert distinct effects on αSyn aggregation: S129Phos has been reported to either inhibit or promote aggregation, whereas Y136DOPA induces the formation of short oligomeric species. To gain insight into the molecular basis underlying the initiation of αSyn multimerization, we semisynthesized αSyn carrying either S129Phos or Y136DOPA and prepared recombinant unmodified full‐length αSyn as a control. Vacuum‐ultraviolet circular dichroism (VUVCD) spectroscopy revealed that these αSyn variants in their monomeric states possessed essentially identical secondary structures. These results suggest that the modifications themselves do not induce significant secondary structural changes in monomeric αSyn.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Medical Radiology, Faculty of Health and Medical Sciences, Hiroshima International University, Higashi-Hiroshima, Hiroshima, Japan.
- Institute for Protein Research, The University of Osaka, Suita, Osaka, Japan.
- Graduate School of Life Science, Kobe Women's University, Kobe, Hyogo, Japan.
- Research Institute for Synchrotron Radiation Science, Hiroshima University, Higashi-Hiroshima, Hiroshima, Japan.
- Department of Functional Anatomy and Neuroscience, Graduate School of Medicine, Nagoya University, Nagoya, Aichi, Japan.
- Graduate School of Medicine, Department of Basic Medical Science, Osaka Metropolitan University, Osaka, Japan.
ORCID profiles: Tatsuhito Matsuo, Isao Suetake, Satoshi Hashimoto, Koichi Matsuo, Hironobu Hojo
Funding
- Japan Society for the Promotion of Science (JSPS) KAKENHI
Cite
APA
Matsuo, T., Suetake, I., Kimura, M., Hashimoto, S., Matsuo, K., Matsumoto, S., Hirotsune, S., & Hojo, H. (2026). No Significant Secondary Structural Change of α‐Synuclein Monomer by Site‐Specific DOPA or Phosphorylation Introduction in Its C‐Terminal Region. Journal of Peptide Science, 32(9). https://doi.org/10.1002/psc.70118
Vancouver
Matsuo T, Suetake I, Kimura M, Hashimoto S, Matsuo K, Matsumoto S, et al. No Significant Secondary Structural Change of α‐Synuclein Monomer by Site‐Specific DOPA or Phosphorylation Introduction in Its C‐Terminal Region. Journal of Peptide Science. 2026;32(9). doi:10.1002/psc.70118
BibTeX
@article{Matsuo2026,
author = {Matsuo, Tatsuhito and Suetake, Isao and Kimura, Mariko and Hashimoto, Satoshi and Matsuo, Koichi and Matsumoto, Sakiko and Hirotsune, Shinji and Hojo, Hironobu},
title = {No Significant Secondary Structural Change of α‐Synuclein Monomer by Site‐Specific DOPA or Phosphorylation Introduction in Its C‐Terminal Region},
journal = {Journal of Peptide Science},
year = {2026},
volume = {32},
number = {9},
doi = {10.1002/psc.70118}
}
EUVIMED